A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

Patients with PsA who are treated with CTT are not at a greater risk for serious or opportunistic infections compared with standard therapy.

Prostate cancer is among the most common types of cancer found in men. It develops in the prostate gland, a small organ ...

Grape seed extract—a dietary supplement made from the seeds of wine grapes—has been investigated to see if it can help reduce ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...

Adding the drug enzalutamide to standard hormone therapy reduced the risk of premature death by more than 40% in patients ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

Dr. Leanne Woods-Burnham of Morehouse School of Medicine discusses the urgent need for Black men to push for early cancer ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

Background Data on cardiorespiratory fitness (CRF) in psoriatic arthritis (PsA) are scarce. This study aimed to determine the ...

Statistics, and the standard deviation of our tests, mean that if you order a complete metabolic profile, a lipid panel, a ...